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DNA Mismatch Repair and its Role
in Huntington’s Disease
Ravi R. Iyera,∗ and Anna Pluciennikb,∗
aCHDI Management/CHDI Foundation, Princeton, NJ, USA
bDepartment of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, PA, USA
Abstract. DNA mismatch repair (MMR) is a highly conserved genome stabilizing pathway that corrects DNA replication
errors, limits chromosomal rearrangements, and mediates the cellular response to many types of DNA damage. Counter-
intuitively, MMR is also involved in the generation of mutations, as evidenced by its role in causing somatic triplet repeat
expansion in Huntington’s disease (HD) and other neurodegenerative disorders. In this review, we discuss the current state
of mechanistic knowledge of MMR and review the roles of key enzymes in this pathway. We also present the evidence
for mutagenic function of MMR in CAG repeat expansion and consider mechanistic hypotheses that have been proposed.
Understanding the role of MMR in CAG expansion may shed light on potential avenues for therapeutic intervention in HD.
Keywords: DNA mismatch repair, Huntington’s disease, DNA structures, triplet repeat instability, somatic expansion, neu-
rodegeneration
INTRODUCTION
DNA repair processes are characterized by their
ubiquity across all domains of life [1]. These mech-
anisms have evolved to maintain genomic stability,
especially in light of the high levels of DNA dam-
age generated by exogenous and endogenous agents
such as ultraviolet light, ionizing radiation, and reac-
tive chemical species. Errors made by DNA synthetic
enzymes (either during the normal course of cell
division or perhaps while carrying out DNA repair
itself) further imperil the integrity of the genetic
information [1, 2]. Replicative DNA polymerases
make base insertion errors infrequently (at a rate of
∼10–4–10–5), and their fidelity is further enhanced
∗Correspondence to: Ravi R. Iyer, CHDI Management/CHDI
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foundation.org.; Anna Pluciennik, Department of Biochemistry
and Molecular Biology, Thomas Jefferson University, Philadel-
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by ∼100 fold by the exonucleolytic proofreading
machinery associated with many such enzymes [2].
Errors that escape these mechanisms are rectified by
the highly conserved DNA mismatch repair (MMR)
pathway, which confers an additional ∼100–1000
fold enhancement in fidelity [3–7]. In addition to its
role in error correction and replication fidelity, MMR
also plays important roles in preventing chromosomal
rearrangements and mediating the cellular response
to several types of DNA damage [8–10].
The importance of MMR is exemplified by the pro-
found consequences of its loss. MMR defects result
in a 100–1000 fold elevation in mutation rate in
most organisms [3–7], and modulation of MMR has
been suggested to be a powerful evolutionary sur-
vival mechanism [11, 12]. Loss of MMR function in
humans is the cause of Lynch syndrome, a hereditary
cancer predisposition condition that is characterized
by an increased risk of gastrointestinal, uterine, and
ovarian tumors [13, 14]. More recently, biallelic
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76 R.R. Iyer and A. Pluciennik / DNA Mismatch Repair and Huntington’s Disease
inactivation of MMR has been linked to constitutive
mismatch repair deficiency syndrome (CMMR-D), a
rare childhood/young adult condition associated with
a higher propensity for developing colorectal, brain,
and blood cancers [15–17]. In addition, MMR defects
underlie a significant subset of sporadic tumors across
various tissues [18]. Current evidence suggests that
the high mutation load of MMR-deficient tumors
results in neoantigen production, rendering such can-
cers highly sensitive to immune checkpoint inhibitors
such as pembrolizumab and nivolumab, resulting in
dramatic improvements in patient survival rates [19].
Counterintuitively, this mutation prevention mech-
anism can in some instances be subverted to produce
mutations. This phenomenon is exemplified by the
requirement of MMR proteins for somatic hyper-
mutation, a mutagenic process in B lymphocytes
that generates immunoglobulin diversity [20–22].
This type of MMR-dependent mutagenesis has been
attributed to a non-canonical MMR (ncMMR) mech-
anism which is activated in a variety of cell types,
and is independent of DNA replication [23–25]. A
number of MMR proteins have also been impli-
cated in triplet repeat expansions that underlie several
neurodegenerative diseases, including Huntington’s
disease (HD) [26–28]. Herein, we review what is
known about the molecular mechanisms of MMR,
and consider its role in somatic CAG triplet repeat
expansion in HD.
MECHANISM OF MISMATCH REPAIR
Mismatches, strand slippage, and extrahelical
extrusions
The best understood function of MMR is its abil-
ity to efficiently correct mistakes made by DNA
polymerases during DNA synthesis [3, 5–7, 29]. A
number of factors involved in the error-correction
reaction have been identified and are listed in Table 1.
Replication errors may be base substitution errors that
result in a base-base mismatch, or strand slippage
errors that generate an extrahelical extrusion or loop.
Inability to rectify these errors result in transitions,
transversions, and small insertion/deletion mutations.
Although the bulk of base insertion errors occur dur-
ing DNA replication, they may also occur during
repair DNA synthesis in non-replicating cells, and
such mistakes if left unrectified could be a significant
source of mispairs.
Strand-slippage errors occur with high frequency
within microsatellite sequences (e.g., mono-, di-,
and trinucleotide repeats), the repetitive nature of
which renders them particularly prone to the forma-
tion of extrahelical extrusions by strand misalignment
[30–33]. In principle, two DNA strands can misalign
not only during DNA synthesis but also whenever
the duplex strands separate and reanneal during DNA
metabolic processes such as transcription. Helix
opening can also be driven by the energy of negative
supercoiling. While superhelical tension in eukary-
otic cells is normally kept restrained by nucleosomes,
release of negative superhelicity upon nucleosome
disassembly can cause transient helix destabilization
[34]. Likewise, helix opening due to accumulation of
negative superhelical tension within the underwound
DNA in the wake of a translocating RNA polymerase
has been documented [35, 36]. Thus, duplex melt-
ing within repetitive DNA tracts can occur under a
variety of circumstances, resulting in the formation
of extrahelically extruded slipped-strand structures.
It is noteworthy in this regard that long CTG repeat
tracts are among the strongest nucleosome binding
sequences known due to their high intrinsic nega-
tive superhelical writhe [37, 38]. These observations
may explain why CTG repeats may be particularly
prone to supercoil-induced spontaneous helix open-
ing and formation of slipped-strand structures. In
fact, slipped-strand structures readily form both in
vitro and in vivo, are structurally heterogeneous, and
thermodynamically stable [33, 39, 40]. Thus, extrahe-
lically extruded slipped strand structures could form
within resting DNA repeat tracts in non-dividing cells
such as neurons during DNA repair, transcription, or
chromatin remodeling.
Mismatch recognition
To deal with the diversity of base-base mismat-
ches and extrahelical loops that are generated
during DNA metabolic processes [2], eukaryotic
MMR has evolved a modular approach to mispair
recognition, employing one of two heterodimeric
MutS homologs, MutS (MSH2-MSH6) and MutS
(MSH2-MSH3) (Fig. 1). MutS recognizes base-
base mismatches and small DNA extrusions (1–4
extrahelical residues), and MutS exclusively recog-
nizes DNA extrusions of 2 to about 10 extrahelical
residues [3]. The structural basis for the mismatch
recognition has been clarified by crystallographic
studies of MutS, MutS, and bacterial MutS
homologs in complex with mispair- or lesion-
containing DNA substrates [41–44]. These studies
have shown that mismatch recognition is asymmetric:
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Table 1
MMR proteins and their functions
Protein Representation Activity Function
MutS ATPase, DNA binding Mismatch recognition (base-base and small extrusions)
MutS ATPase, DNA binding Mismatch recognition (extrusions only)
MutL ATPase, Endonuclease Introduction of strand breaks
MutL ATPase, Endonuclease DNA structure- and strand-specific nicking
MutL ATPase Unknown (suggested to be an accessory factor)
PCNA Sliding clamp Strand-directionality factor
RFC ATPase Loads PCNA onto the DNA
EXOI 5’–3’ exonuclease Exonucleolytic removal of error-containing strand
Polδ DNA polymerase Strand synthesis (also carries out strand displacement)
LIG1 Not shown DNA ligase Ligation of strand-breaks post repair DNA synthesis
whereas MSH2 makes limited contact with the DNA
in both MutS and MutS, extensive interactions
occur between residues in MSH3 and MSH6 with
the heteroduplex [41, 42].
Because of their overlapping substrate recogni-
tion specificities, MutS can largely compensate
for the absence of MutS, and the overwhelming
majority of mispairs are recognized and rectified
by a MutS-initiated pathway. Hence, MutS is
critical for mutation avoidance, and its inactivation
(by mutations in MSH2 or MSH6) is a risk fac-
tor for carcinogenesis [13, 14]. By contrast, loss
of MutS function (by inactivation of MSH3) has
not been conclusively linked to an elevated cancer
risk in humans [45]. Consistent with these observa-
tions, mice lacking MSH2 or MSH6 display increased
susceptibility to spontaneous tumorigenesis and an
attenuated lifespan, whereas MSH3 knockout mice
are indistinguishable from wild-type mice both in
terms of tumorigenicity and life expectancy [46–49].
These striking differences are particularly relevant in
light of the observation (considered below) that CAG
somatic expansion is attenuated in HD mice lacking
Msh2 or Msh3 (but not Msh6), thus suggesting that
pharmacological modulation of MSH3 may pose a
lower risk than targeting MSH2 or MSH6.
In addition to their DNA binding functions,
MutS and MutS possess ATP hydrolytic activi-
ties and belong to the ABC (ATP Binding Cassette)
ATPase superfamily [41, 42]. The MutS and MutS
ATPases are stimulated by heteroduplex DNA, an
effect that is indicative of long-range conformational
changes elicited by DNA cofactor binding at a site
distal to the nucleotide pocket [50–55]. Although the
functional significance of ATP binding/hydrolysis of
MutS homologs has been the subject of intense debate
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Fig. 1. Mechanisms of 5′ and 3′ human mismatch repair. Distinct molecular mechanisms mediate mismatch repair, depending on strand-break
polarity. Left, DNA mismatches or extrahelical extrusions are recognized by MutS or MutS. When the strand-break is located 5′ to the
mismatch, MutS/ activates the processive 5′–3′ exonuclease activity of ExoI in an ATP-dependent manner. The ensuing gap is protected
by the single-stranded DNA binding protein complex RPA, followed by DNA resynthesis across the gap by DNA polymerase δ, aided by
the replication sliding clamp PCNA and the clamp loader RFC. Right, if the strand-break is located 3′ to the mispair, error correction relies
on oriented loading of PCNA by RFC at the strand break. Thus, MutS/ recruits MutL in an ATP-dependent manner, resulting in the
activation of a latent endonuclease function in MutL in the presence of DNA-loaded PCNA. The additional strand-breaks catalyzed by
MutL bracket the mismatch, and facilitate processive 5′–3′ hydrolysis of the nicked strand by MutS-activated ExoI. Gap protection and
filling occur as in the 5′ nick-directed reaction.
for over three decades, there is general agreement that
inactivation of the ATPase function is deleterious for
overall mismatch repair [3, 4]. Consequently, such
mutations result in elevation in mutation rate in bac-
teria [56] and a higher cancer predisposition risk in
humans [42].
Formation of mismatch repair protein assemblies
and mismatch removal
Mismatch recognition by MutS/ is followed by
the recruitment of the heterodimeric MutL (MLH1-
PMS2). MutL homologs belong to the GHKL ATPase
superfamily that is characterized by the unique
Bergerat ATP-binding fold [57]. Although detailed
structure-function studies of the MutL ATPases
are lacking, structures of both MLH1 and PMS2
ATPase domains are available [58–60], and bio-
chemical and genetic studies have shown that the
MutL ATPase function is required for MMR [61–63].
Interaction between MutS/ and MutL results in
the formation of a dynamic ATP-dependent DNA-
MutS/-MutL ternary complex that is required for
MMR [64–72]. These observations have led to the
notion that ATP binding/hydrolysis drives conforma-
tional changes in MutS homologs (and presumably in
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MutL homologs as well), thereby facilitating ternary
complex assembly.
The PMS2 subunit of MutL harbors a latent
zinc-dependent endonuclease that is activated by
DNA-loaded replication sliding clamp PCNA (pro-
liferating cell nuclear antigen) in the presence of
MutS/, a mispair, and ATP-Mg+2 [73–75]; this
activity depends on the integrity of a conserved
metal-binding DQHA(X)2E(X)4E motif and requires
a physical interaction between PMS2 and PCNA
[74–76]. The MutL-catalyzed strand breaks are
restricted to the strand harboring a pre-existing break
(and hence assumed to harbor the incorrect base)
and bracket the mismatch on both 3′ and 5′ sides
(Fig. 1); these breaks provide initiation sites for exci-
sion of the strand harboring the incorrect base as
discussed below. The importance of MutL in the
MMR reaction is highlighted by the observation that
loss of MLH1 or PMS2 not only results in elevation
of mutation rate, but also increases the lifetime risk of
tumorigenesis in both mice and humans [77]. Interest-
ingly, both MLH1 and PMS2 have been identified as
onset modifiers of HD, and loss of Mlh1 or Pms2 sub-
stantially attenuates somatic triplet repeat expansion
in animal and cellular models of HD, myotonic dys-
trophy type 1 (DM1), and Fragile X-related disorders
(FXDs) [78–80].
Mismatch excision is carried out by the 5′ to 3′
hydrolytic activity of EXO1, the only exonuclease
that has been identified in eukaryotic MMR. EXO1,
an otherwise distributive enzyme (i.e., it excises only
a few nucleotides at a time from the DNA before
it dissociates), is rendered highly processive (i.e.,
capable of removing hundreds of nucleotides without
having to dissociate) when it associates with MutS
in the presence of a mispair and ATP. Loading of
MutS-activated EXO1 at 5′ DNA termini results in
processive strand excision that proceeds until the mis-
match is removed [81–83]. This MutS-stimulated
EXO1 reaction relies on pre-existing 5′ ends (but not
3′ ends) such as those that exist in Okazaki fragments
on the lagging strand of DNA replication [3–7], and
is notable in its lack of an absolute requirement for
MutL [84] (Fig. 1).
In the presence of MutL however, the MMR
system can utilize either pre-existing 5′ or 3′ DNA
termini. In fact, the 3′ nick-directed reaction dis-
plays an absolute requirement for MutL [74, 81,
85, 86] (Fig. 1). The additional strand-breaks intro-
duced by the activated MutL endonuclease serve
as initiation sites for processive 5´ to 3´ excision
by MutS/-activated Exo I [74, 81, 82, 87]. The
ensuing EXO1-catalyzed gap is protected by the
single-stranded DNA binding protein RPA, followed
by resynthesis with high fidelity by DNA polymerase
δ (Polδ), and ligation by DNA ligase I, thereby main-
taining the integrity of the genetic information [83,
85, 86, 88]. Interestingly, EXO1-independent mis-
match repair has also been documented wherein Pol δ
conducts strand displacement synthesis initiated from
3′-OH DNA termini, thereby replacing the strand that
contains the incorrect information [87].
Mammalian cells also express two other MutL
complexes—MutL (MLH1-MLH3) and MutL
(MLH1-PMS1). Both MLH3 and PMS1 are GHKL
ATPases, but only MLH3 possesses the metal-
binding endonuclease motif found in PMS2 [74].
However, although MutL endonuclease is activated
by DNA-bound MutS, unlike MutL this effect
does not require DNA-loaded PCNA [89–91]. The
primary function of MutL is in meiotic recombi-
nation wherein it plays an essential role wherein
the MutL endonuclease is activated by MutS
(MSH4-MSH5), and to a lesser extent by RFC,
PCNA, and EXO1 [92–95]. MutL also plays a
modest role in MMR since loss of MLH3 func-
tion results in a moderate increase in mutation rates,
and in vitro complementation of MLH1-deficient
cells with MutL-enriched fractions results in partial
restoration of MMR function [96–100]. Consistent
with a possible role for MLH3 in cancer avoidance
[101], Mlh3−/− mice display elevated mutation rates,
increased tumor susceptibility, and reduced lifespans
relative to wild type mice [99, 102]. Interestingly,
whereas human GWA studies have not identified
MLH3 as an HD onset modifier, Mlh3 is required
for CAG and CGG somatic expansions in HD and
FXD mouse models, respectively [80, 103, 104].
As noted above, PMS1 is the only MutL ortholog
that does not contain the DHQA endonuclease motif.
PMS1 interacts with MLH1 to form MutL, a het-
erodimer that associates with MutS or MutS
to form an ATP-dependent DNA-MutS/-MutL
ternary complex [105–109]. However, MutL
appears to have no role in canonical human MMR
as judged by the inability of recombinant MutL to
restore MMR activity to MLH1-deficient cell extracts
[105]. Consistent with these findings, Pms1 knock-
out mice show no observable defects in either MMR
or tumor susceptibility [77]. Nevertheless, studies
with the yeast homolog have indicated a possible
accessory role for MutL in the repair of a sub-
set of heteroduplexes [92, 98, 109]. Thus, although
PMS1 modifies HD onset age [103], given the limited
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understanding of the molecular function of PMS1 or
MutL, the possible mechanisms underlying its role
in HD remain to be investigated.
Strand directionality of mismatch repair
Upon encountering a mismatch, the MMR sys-
tem must act with exquisite strand bias in order to
specifically rectify the strand containing the incor-
rect information. This is achieved by using “strand
signals” that mark one strand relative to the other, and
thus enable the MMR system to distinguish between
the template strand and the newly synthesized strand
(Fig. 1). Whereas in E. coli, DNA hemi-methylation
has been established as the mechanism that directs
the system to the appropriate strand, the iden-
tity of eukaryotic strand signals has been intensely
debated for over three decades. In in vitro biochem-
ical experiments, strand-breaks serve effectively as
strand signals, and mismatch repair of circular
DNA substrates is restricted to the strand that con-
tains a pre-existing break. When such strand-breaks
are located 5′ to the mismatch, MutS/-activated
EXO1 processively and exclusively excises the
nicked strand with 5′-3′ polarity thereby conferring
strand-directionality to the mismatch repair reaction.
However, when the strand-break is located 3′ to the
mismatch, strand directionality is conferred by the
introduction of additional strand-breaks by MutL
in a reaction that also requires MutS/, a mispair,
DNA-loaded PCNA, and ATP. These new strand-
breaks are restricted to the nick-containing strand.
The strand-directional activation of MutL can also
occur when the original strand-break is located 5′ to
the mismatch. The strand bias of the MutL endonu-
clease is determined by the unique spatial orientation
(relative to 3′-OH termini) with which the donut-
shaped PCNA (with its two non-equivalent faces;
Fig. 2) is loaded at DNA strand discontinuities by the
clamp loader replication factor C (RFC). This effect
requires a physical association of oriented PCNA
with the PMS2 subunit of MutL [76]. Thus, it is
relatively straightforward to envision PCNA loaded
at DNA termini as strand signals for MMR in the con-
text of active DNA replication in dividing cells (e.g.,
DNA ends of Okazaki fragments). In fact, recent stud-
ies have suggested that loaded PCNA continues to
direct strand-specific MMR even after the removal of
strand-discontinuities, and that a physical interaction
between MutS and PCNA enhances the tempo-
ral window for effective strand-directed MMR [110,
111]. Thus, persistence of DNA-loaded PCNA after
completion of DNA synthesis can continue to provide
strand-directionality “memory” to the MMR system
[110].
Sequences that adopt unusual DNA secondary
structures are found throughout the human genome
[112–115]. A substantial body of literature supports
the idea that non B-DNA conformations have pro-
found effects on DNA metabolic processes (reviewed
in [26]). The DNA conformational transitions that
govern the formation of these non B-DNA struc-
tures are energetically driven by negative superhelical
tension, which in normal eukaryotic cells remains
constrained within chromatin but can be unleashed
during nucleosome disassembly. Interestingly, such
structures may also affect the strand-directionality
of MMR. DNA molecules that contain “open bub-
bles” (due to unpairing of a segment of the duplex)
could provide sites for loading of PCNA even in
the absence of strand-breaks. Such bubble structures
contain single-strand/double-strand junctions with
mirror symmetry and conformationally resemble
extrahelical extrusions that form by strand slippage
within repetitive DNA tracts (e.g., long CAG/CTG
repeats). PCNA loading at such structures occurs
in either spatial orientation (disoriented loading)
and, consequently, MutS/-dependent activation of
MutL endonuclease on these DNAs also occurs
without substantial strand bias [75, 116, 117]. The
implications of these findings are three-fold. First,
DNA-loaded, spatially oriented PCNA may direct the
strand-specificity of MMR in post-replicative non-
dividing cells. Second, PCNA loading at extrahelical
extrusions such as those formed within long repet-
itive DNA tracts may misdirect the MMR system
and cause it to act aberrantly on both DNA strands
(see below). Third, strand-independent activation of
ncMMR could involve PCNA ubiquitination and
recruitment of error-prone DNA polymerases, result-
ing in repeat instability [23, 118].
Mismatch repair in the context of chromatin
The mechanistic dissection of the MMR reaction
has relied largely on in vitro biochemical stud-
ies using a combination of purified proteins, cell
extracts, and naked heteroduplex DNA substrates
[6]. However, there has been growing interest in
understanding how mismatch repair functions in
the cellular context, especially within chromatin
(for comprehensive review, see [119]. Studies have
established that trimethylation of histone H3 at
lysine 36 (H3K36me3) is required for recruitment
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Fig. 2. Models for involvement of mismatch repair in CAG/CTG repeat expansion. Strand slippage within long repetitive CAG/CTG tracts
results in the formation of extrahelical extrusions that are not only recognized by MutS, but also serve as loading sites for PCNA even
in the absence of strand-breaks. PCNA, a ring shaped homotrimeric protein with two distinct faces (inset, indicated in green and brown)
preferentially associates with its partner proteins via residues on one face. Although the two faces of PCNA are functionally non-equivalent,
due to the symmetry of the extrahelical extrusions, PCNA loading at such structures occurs in both possible spatial orientations. Since the
strand directionality of the MutS-dependent activity of the MutL endonuclease is determined by the orientation of DNA-loaded PCNA,
the disoriented loading of PCNA misdirects MutL catalyzed incisions to either DNA strand. Left, when incision occurs on the extrusion-
containing strand (shown in blue), strand excision results in removal of the extrusion, and faithful repair by Polδ results in a contraction (not
shown). However, error-prone gap resynthesis by Polη or Pol as illustrated in the diagram may provide additional opportunities for strand
slippage and formation of new extrahelical extrusions, which either result in a net increase in CAG repeat length (i.e., expansion) or trigger
additional rounds of MutS-initiated incision/excision. Middle, when MutL-mediated strand-breaks are formed on the complementary
(red) strand, error-free resynthesis by Polδ results in inclusion of the extrusion, leading to a net increase in CAG repeat length (expansion).
Gap resynthesis may also be driven by Pol as on left, resulting in additional strand slippage (not shown). Right, extrusion-bound MutS
can also activate MutL in a PCNA-independent manner. The incisions catalyzed by MutL are restricted to the complementary (red)
strand opposite to the extrusion. DNA resynthesis results in inclusion of the extrusion, leading to a net increase in CAG repeat length
(expansion).
of MutS to replicating chromatin [120]. This effect
is mediated by a physical interaction between the
modified histone and the PWWP domain of the
MSH6 subunit of MutS. The importance of this
histone modification for MMR is established by
the observation that knockdown of SETD2 (a his-
tone methyltransferase that trimethylates H3K36)
causes a mutator phenotype characterized by high
microsatellite instability and an elevated mutation
rate [120]. Mutations in histone H3 (G34V/R/D)
that block H3K36 trimethylation by SETD2 also
inhibit the interaction between H3K36 and MutS;
this mutation not only causes a mutator phenotype
in cells, but also has been identified as a driver of
pediatric glioblastoma [121]. MMR modulation by
histone modification helps maintain genomic stabil-
ity of actively transcribed genes [122]. Not only are
H3K36me3 and MutS co-enriched in exons (rel-
ative to introns and non-transcribed regions), but
also disruption of the H3K36me3-MutS interaction
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elevates the spontaneous mutation rate in actively
transcribed genes, with little influence on non-
transcribed regions. These findings have implications
for the role of MMR in maintaining genomic stability
in non-dividing, but transcriptionally active, cells.
In addition to histone modification, interplay of
the MMR proteins with nucleosome assembly and
remodeling factors has also been documented [123–
125]. MutS and PCNA interact with the nucleo-
some assembly factor CAF-1, and these interactions
inhibit the CAF-1 mediated nucleosome assembly
on mispair-containing DNAs [123–125]. The forma-
tion of the MutS-CAF-1 complex is mediated by
residues within the MSH6 subunit of MutS [123].
Investigations to date have focused on MutS func-
tion in the context of chromatin dynamics. However,
because MSH3 does not possess a PWWP domain
[126], and since no studies have been carried out on
MutS interactions with nucleosome assembly fac-
tors, the mechanisms that recruit MutS to chromatin
are not known.
In the cellular environment, the MMR machinery
is also regulated by post-translational modifica-
tions. Phosphorylation of several MMR proteins—
including MutS, MutL, PCNA, RFC, ExoI, and
Polδ—has been documented, and these modifications
modulate protein-protein interactions, protein stabil-
ity, as well as nuclear-cytoplasmic distribution [127].
A full mechanistic understanding of these diverse
effects is still underway; nevertheless, based on avail-
able data it is expected that future investigations will
unravel novel aspects of MMR regulation by post-
translational modification.
Other functions of mismatch repair
In addition to its role in mismatch correction, the
MMR machinery also mediates the cellular response
to several types of DNA damage [8, 9, 128] and pre-
vents illegitimate recombination [10]. However, these
functions of MMR are not currently thought to play a
role in triplet repeat instability [3, 26, 129], and will
therefore not be considered further.
Mismatch repair in the central nervous system
(CNS)
Our current understanding of canonical post-
replicative DNA mismatch repair is based on fun-
ctional studies in dividing cells complemented by
mechanistic biochemical investigations. Because the
primary phenotype of loss of mismatch repair activ-
ity is elevation in mutation rate, and since mutation
rate measurements are (by definition) not feasible
in non-replicating cells, the role of MMR in termi-
nally differentiated cells such as neurons has not been
studied extensively. Yet, the functional importance
of MMR in the brain is underscored by the observa-
tion that ∼50% of CMMR-D patients who harbor
biallelic germline mutations in one of four MMR
genes (MSH2, MSH6, MLH1, and PMS2) develop
brain tumors of various types including glioblas-
tomas, astrocytomas, and oligodendrogliomas [16].
Cells derived from such tumors display low levels
of MMR activity [130]. Immunohistochemistry and
immunoblot analyses have established that MSH2,
MSH6, MSH3, MLH1, and PMS2 are robustly
expressed in normal human and rodent brains,
suggesting that these proteins have functional sig-
nificance [80, 131–136]. Insofar as MMR protein
levels are reflective of the capacity of the brain to
rectify mismatches, the lack of replicative errors in
terminally differentiated brain cells suggest that mis-
matches must occur post-mitotically.
Because the brain consumes ∼20% of the total
oxygen budget of the human body to support neu-
ronal activities, it is also subjected to high levels of
oxidative stress, a condition that has been correlated
with oxidative DNA damage and accumulation of
DNA strand breaks [137–140]. Therefore, base exci-
sion repair (BER), single-strand break repair (SSBR),
and double-strand break repair (DSBR) mechanisms
are highly active in the CNS, and in fact, defects in
these repair pathways are the cause of several neu-
rodegenerative diseases [139, 141, 142]. Physical and
functional cross-talk between MMR and BER pro-
teins has been documented [143], and therefore it
is plausible that MMR factors may be recruited to
sites of BER activity in neurons. It is also possible
that even limited gap filling DNA synthesis during
BER, DSBR, or SSBR may provide ample opportu-
nities over several decades of human life for DNA
polymerases to make errors that may then require the
attention of the MMR system. Nevertheless, direct
evidence for MMR activity in neurons is lacking,
and although nuclear extracts prepared from rat brain
retain mismatch binding activity [132], the capac-
ity of whole brain or neuronal extracts to repair
mismatches or extrahelical extrusions has not been
studied, and brain- or neuron-specific MMR factors
have not been identified. Therefore, biochemical and
cellular studies of MMR function in brain-derived
cells and tissues is likely to be a fruitful and instructive
avenue of investigation.
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ROLE OF MISMATCH REPAIR IN
HUNTINGTON’S DISEASE
The diverse genome-stabilizing activities of MMR
notwithstanding, this pathway has also been impli-
cated in mutation production in the context of
neurodegenerative disease. The most compelling cor-
pus of data in this regard pertains to HD and will be
considered here, although recent findings have also
suggested a role for MMR in the repeat expansions
underlying FXDs and Friedreich’s ataxia [78, 104,
144–147].
HD belongs to a family of slow-progressing neu-
rodegenerative disorders caused by CAG triplet
repeat expansions within the coding regions of dis-
tinct and unrelated genes [148]. A key feature of
HD (and indeed other triplet repeat diseases as well)
is the strong inverse correlation between the inher-
ited length of the CAG repeat tract (located within
exon1 of the Huntingtin HTT gene) and the age
of disease onset [148, 149]. Moreover, HD gene
expanded carriers (HDGEC) display high levels of
CAG repeat expansion, not only in the germline, but
also in somatic cells wherein such expansions occur
in a tissue-specific manner: the greatest degree of
expansion is observed in the terminally differentiated
neurons of the striatum and cortex [131, 150–152]
[153]. Recent studies have established that the inher-
ited length of uninterrupted CAG repeats rather than
the length of the encoded polyQ tract, (since both
CAA and CAG can encode glutamine) modifies dis-
ease onset [103, 154–156]. Because uninterrupted
repeats are thought to have a higher propensity
to expand than repeat tracts harboring CAA inter-
ruptions, it has been suggested that somatic CAG
instability is a key driver of CAG length dependent
HD pathogenesis [103, 154, 155]. One implication of
these observations is that factors that hasten or atten-
uate CAG-repeat instability may also be expected to
affect disease onset. It is noteworthy that a recent
study has suggested a role for huntingtin protein lev-
els in promoting CAG repeat expansion in knock-in
mouse models of HD and spinocerebellar ataxia type
2, as well as in HD patient iPS-derived medium spiny
neurons, although the pathways underlying these
effects are yet to be delineated [157].
Genetic evidence for the role of MMR in HD
Recent human genome-wide association studies
(GWAS) have identified genetic modifiers of age at
disease onset that map to a constellation of DNA
repair genes that include the MMR genes MSH3,
MLH1, PMS1, PMS2, as well as LIG1, and FAN1
[103, 148, 158–163] (Table 2). In the case of MSH3,
a genetic variant that is associated with reduced
gene expression and/or function appears to not only
delay age at onset, but also reduce somatic instabil-
ity and disease severity in HD and DM1 patients
[161]. Curiously, this MSH3 variant itself arises
from instability of a 9-bp tandem repeat that codes
for an alanine repeat element near the N-terminus
of the MSH3 polypeptide [161]. Repeat instability
measurements in the blood have revealed effects of
polymorphisms in MSH3, MLH1, MLH3, and FAN1
on somatic CAG-repeat variation in HDGEC [155],
and of MSH3 genetic variants on CTG repeat instabil-
ity in DM1 patients [164]. Effects of MSH3 and FAN1
on HD progression have also been documented [148,
158, 161, 163]. These observations made in human
HD patients suggest that the MMR pathway influ-
ences both disease onset and progression and, taken
together with data from HD mouse models, imply that
disease manifestation is modulated by somatic CAG
expansion.
A pathogenic role for a genome stabilizing DNA
repair system in human disease may seem counterin-
tuitive; nevertheless, multiple lines of evidence have
converged in recent years to point to MMR as a likely
culprit in CAG-repeat expansion. The earliest evi-
dence that MMR genes may promote triplet repeat
instability emerged from studies in E. coli, wherein
inactivation of the MMR genes mutS, mutL, or mutH
resulted in a dramatic reduction of CTG/CAG repeat
instability [165, 166]. The mutagenic role of MMR
in mammals was conclusively established by work in
rodent models of HD and DM1 wherein inactivation
of MMR strongly attenuated both somatic expan-
sion of the CAG/CTG repeats in multiple tissues as
well as intergenerational repeat expansion (although
it is unclear whether somatic and intergenerational
expansions are mediated by the same molecular
mechanism(s)) [79, 80, 167–177]. Germline knock-
out of either of the MutS homologs Msh2 or Msh3
or the MutL homologs Mlh1 or Mlh3 in an HttQ111
knock-in mouse model of HD blocks somatic CAG
expansions in the striatum. Loss of Msh2, Msh3, or
Mlh1 also reduces nuclear accumulation of mHTT
protein, suggesting not only that CAG somatic expan-
sions are associated with some aspects of mHTT
pathology, but also that inactivation of MMR can
mitigate such disease-associated signatures [80, 170,
175, 177]. Similarly, Msh2, Msh3, and Pms2 have























Summary of genes implicated in HD. The ratios of observed versus expected genome variants for each of the genes was derived from the gnomAD database [211], and are reflective of how tolerant
a gene is to genetic variation. A low o/e score is indicative of stronger selection for the gene and lower tolerance for loss of function (LoF). Phenotypic effects of variants, knockout, or knockdown





Effects of variants in HD GWA
studies
Effect of gene knockout or reduced expression LoF pathology (other
human diseases)
HD mouse models Mouse models of other triplet
repeat diseases
Cellular systems for triplet
repeat expansion
MSH2 0.192 - Attenuates CAG repeat
expansion [167, 168, 170, 177,
212]
Attenuates CTG and CGG
repeat expansions in DM1 and
FXD mice, respectively [171,
172, 176, 213]
Knockdown attenuates CTG
and GAA repeat expansions
[145, 214–217]
Lynch syndrome [13, 18],
CMMR-D [15–17]
MSH3 0.912 Increased expression hastens
onset; reduced expression
delays onset/ progression [103,
161, 163]
Attenuates CAG repeat
expansion [173, 175, 218]
Attenuates CTG and CGG
repeat expansions in DM1 and
FXD mice, respectively [144,
169, 174]
Knockdown attenuates CTG
and GAA repeat expansions
[145, 215, 216]
-
MSH6 0.336 - Limited effect on CAG repeat
contraction [175]
No effect on CTG repeat
expansion in DM1 mice [169]
Knockdown does not affect
CTG or GAA repeat
expansions [145, 215, 216]
Lynch syndrome [13, 18],
CMMR-D [15–17]
MLH1 0.373 Missense (LoF?) variant delays
onset [103, 155, 159, 162]
Attenuates CAG repeat
expansion [80, 205]
- Knockdown attenuates GAA
repeat expansions [146]
Lynch syndrome [13, 18],
CMMR-D [15–17]
PMS2 0.976 Delay of onset by variant with
unknown effect; missense
variant hastens onset [103,
160]
- Attenuates CTG repeat
expansion in DM1 mice [79]
Knockout attenuates CGG
repeat expansion [78]
Lynch syndrome [13, 18],
CMMR-D [15–17]
PMS1 0.755 Reduced expression hastens
onset [103]
- - Knockout attenuates CGG
repeat expansion [78]
-
MLH3 0.411 Variant associated with somatic




expansion in FXD mice [104]
Knockout attenuates CGG and
GAA repeat expansions [78,
146]
-
LIG1 0.288 Missense (LoF) variant delays
onset; increased expression
hastens onset [103]
- No effect on somatic CTG






FAN1 0.864 Missense (LoF) variants hasten
onset; increased expression












R.R. Iyer and A. Pluciennik / DNA Mismatch Repair and Huntington’s Disease 85
models of DM1, suggesting that MutS and MutL
play a role in this process [79, 169, 171, 172, 176].
Interestingly, studies in a mouse model of FXD has
identified Msh3 as a driver of somatic CGG repeat
expansion [144].
Although the MMR system drives CAG repeat
expansion, the overall increase in CAG repeat number
may be a net consequence of individual expansion and
contraction events. This type of expansion “biased”
instability has been documented in the blood of DM1
patients [178, 179]. Bidirectional CAG somatic and
intergenerational instability has also been observed
in both DM1 and HD mouse models, with longer
inherited CAG or CTG repeat tracts subject to higher
rates of contraction versus expansion [170, 171, 175,
180]. Thus, it seems likely that factors that alter
the balance between expansion and contraction may
modulate disease onset. In fact, it has been sug-
gested that genetic or pharmacological approaches
to induce CAG repeat contractions might hold thera-
peutic promise [181, 182]. However, the mechanistic
role of MMR proteins in controlling the balance
between expansion and contraction remains poorly
understood.
A striking feature of the tissue-specificity of
somatic instability in HD is that the striatum and the
cortex (the most severely affected parts of the CNS in
HD patients) display high levels of CAG expansions;
by contrast, CAG repeats are relatively stable in the
cerebellum, which is pathologically unaffected [150,
151, 183]. In the periphery, CAG repeat expansions
are observed in the liver, although this tissue does not
display disease pathology. The simplest interpreta-
tion of these findings is that (a) the cellular milieu
of striatal medium spiny neurons is more permis-
sive to MMR-dependent CAG repeat expansion than
the environment within cerebellar Purkinje or granule
cells, and (b) cell vulnerability likely involves tissue-
or cell-type specific factors that may render the stria-
tum more susceptible to the consequence of CAG
expansion than the liver. Since medium spiny neurons
and Purkinje cells are both post-mitotic, differences
in CAG instability between these cell types must arise
due to factors other than cell division. It has been sug-
gested that transcriptionally active genes are subject
to higher levels of MMR than silent genes or non-
transcribed regions of the genome [122, 184, 185]. In
fact, transcription-mediated destabilization of CAG
and CTG repeats has also been documented in in
vitro systems [186–188], and a small-molecule that
induces CAG repeat contractions in a transcription-
dependent manner has been reported [182]. Thus, it
is possible that locus-specific CAG repeat instability
may be transcription-dependent. In summary, studies
of MMR in different neuronal sub-types and its inter-
face with transcription in these cells is likely to shed
light on the possible mechanisms underlying CAG
repeat instability in humans.
Mechanisms of MMR-mediated CAG repeat
expansion
It has been known for over half a century that the
two DNA strands within repetitive DNA elements
have a high propensity to slip relative to one another,
and that slippage-mediated mispairing of the DNA
strands can give rise to changes in repeat tract length
[30, 189, 190]. The probability of strand slippage
is governed by the sequence composition as well
as the number of repeating units within the repet-
itive element, meaning that a vital determinant of
mutagenic propensity is encoded within the DNA
sequence itself. An example of this phenomenon is
the tendency of the CAG/CTG repeat in exon1 of
the HTT gene to undergo length changes (thereby
driving HD) by mechanisms presumed to involve
strand slippage within the repeat tract. This results
in the formation of extrahelical extrusions composed
of CAG or CTG repeats, structures that are natural
substrates for MutS. Studies from several labo-
ratories have established that (CAG)1,2,3,4,7,or13 or
(CTG)1,2,3,4,or13 extrahelical extrusions are recog-
nized by MutS with high affinity in vitro, with
reported dissociation constants ranging from 4–35
nM [51, 116, 173, 191]. Because MutS recognizes
non-triplet repeat extrahelical extrusions with simi-
lar affinities, it is generally believed that the structure
of the extrusion (rather than its sequence composi-
tion) governs the protein-DNA interaction [50, 51,
67, 173].
The general consensus is that extrahelical extru-
sions composed of 5 or more CTG or CAG units are
rectified efficiently by a MMR-independent mecha-
nism (as judged by robust repair of such extrusions
by extracts of cells deficient in MSH2 or MLH1)
[192–194]. These findings are consistent with pre-
vious observations that rectification of large loops
(>12 nucleotides) in human cells is independent of
canonical mismatch repair, although the molecular
mechanisms governing these events have not been
fully clarified [195–198]. By contrast, small extra-
helical loops (1–4 triplet repeats) are not only high
affinity substrates for MutS binding but are also sub-
ject to robust rectification by the MMR system in cell
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extracts, and repair activity is dependent on MutS
[116, 199, 200]. Interestingly, repair of CAG and
CTG extrusions also requires an MLH1-containing
heterodimer since the reaction is not supported by
extracts prepared from cells lacking MLH1 [116,
200]. Repair activity can be restored to MLH1-
deficient extracts by supplementation with purified
recombinant MutL [116], indicating that this het-
erodimer suffices for this purpose. Furthermore, the
inability of PMS2-deficient HEC-1A cell extracts to
support repair of a (CTG)1 extrusion suggests that
a PMS2-containing heterodimer is required for this
process [200]. The inability of a PMS2 endonuclease-
inactive MutL derivative to restore (CAG)2 loop
repair capacity to MLH1-deficient extract demon-
strates that MutL plays a catalytic role in extrusion
repair, and that the strand incisions it catalyzes are
critical intermediates in the MutS-dependent pro-
cessing of small triplet repeat loops [116]. Thus,
although CAG hairpins harboring 5 or more repeats
are routinely invoked as hypothetical substrates that
initiate repeat expansion, available evidence suggests
that such hairpins are refractory to the MMR path-
way. Because shorter CAG or CTG extrusions (1–4
repeats) not only trigger recognition by the MMR
pathway, but also display preferential processing by
a MutS- (rather than a MutS-) initiated repair
process, such extrahelical extrusions are the presump-
tive substrates that drive somatic CAG expansions in
human cells.
As noted earlier, activation of the MutL endonu-
clease on bubble structures occurs without strand
bias, presumably due to the disoriented loading of
PCNA onto the DNA. Interestingly, triplet repeat
extrahelical extrusions behave in much the same way
as bubble structures. PCNA is loaded by RFC effi-
ciently on DNAs harboring a (CTG)1–3 or (CAG)1–3
extrahelical extrusion, and in the presence of MutS,
MutL, and ATP, strand incision activity is directed
to both DNA strands [116]. Thus, these extrahe-
lical extrusions (although restricted to one strand,
and lacking a juxtaposed complementary strand
extrusion) not only provoke their recognition by
MutS, but also dysregulate the strand-directionality
of the MutL endonuclease. Such MutL catalyzed
non-strand-specific breaks stimulates DNA synthetic
activity on both DNA strands in cell extracts [116],
opening up the possibility for further strand-slippage
and expansion. Because these events are not cou-
pled to DNA replication, the “dysregulated strand
directionality” model (Fig. 2) has been suggested to
play a role in CAG-repeat expansion in post-mitotic
neurons in the striatum [26, 116]. In this model,
expansions/contractions occur either due to the repair
of double-strand breaks caused by MutL-catalyzed
incisions in close proximity to one another on the
two strands (not shown), or during DNA re-synthesis
of the gaps generated upon excision of the nicked
strand. Whereas faithful resynthesis by Polδ results
in a contraction (not shown), strand-slippage during
error-prone resynthesis by Pol or Polη results in
an expansion. Alternatively, expansion can occur by
inclusion of an extrahelical extrusion into the primary
structure of the DNA. Overall expansion may be a net
result of individual expansion and contraction events,
as has been suggested to occur in both HD and DM1
[178, 179]. In fact, there is evidence that recruitment
of DNA polymerase  (Pol) by MutS to CAG or
CTG extrusions triggers error-prone DNA resynthe-
sis in vitro, resulting in expansions [201]. It has also
been suggested that the MutS-Pol complex may
promote CAG-repeat expansion during base exci-
sion repair (BER) [202, 203], although the interplay
between the MMR and BER pathways in CAG-
repeat expansion remains to be fully dissected [26].
Also, given the limited processivity of Pol (1–6
nucleotides) [204], it is unclear as to how it might
carry out error-prone synthesis of disease-relevant
CAG repeat tracts. Error-prone DNA synthesis has
also been invoked to explain non-canonical MMR-
mediated mutagenesis [23]. This process has been
suggested to involve processive reiterative DNA syn-
thesis of long triplet repeat tracts by Polη. However,
the involvement of Polη in CAG strand slippage is
yet to be experimentally validated.
An alternate model (Fig. 2) for CAG expansion
has invoked PCNA-independent activation of the
MutL endonuclease by MutS on CAG extrahelical
extrusions. Whereas PCNA-directed MutL endonu-
clease activity on such molecules produces nicks on
both DNA strands [116], the MutL-catalyzed inci-
sions are restricted to the strand complementary to
the extrusion. Based on these observations, it has
been proposed that DNA re-synthesis induced by the
strand-break result in retention of the extrusion, lead-
ing to a net expansion of 1 CAG unit [91].
These models provide a mechanistic framework to
understand the role of MutL and MutL in CAG-
repeat expansion; nevertheless, the GWAS have also
suggested a role for PMS1 and FAN1 in modulat-
ing the process. Repeat instability measurements in
cell lines have established that overexpression of wild
type (but not catalytically inactive) FAN1 attenuates
CAG-repeat expansion [158] (considered in detail
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elsewhere in this issue). Recent studies have shown
that CAG somatic expansions are enhanced in an
HttQ111 knock-in mouse model of HD that also
lacks Fan1 [205]. These instabilities are abolished
by the additional knockout of Mlh1, suggesting that
CAG expansions in the absence of Fan1 require func-
tional Mlh1 [205]. Interestingly, knockout of Fan1
also exacerbates CGG repeat expansion in a mouse
model of FXD [206]. These findings suggest a gener-
alized protective role for FAN1 in repeat expansion,
although the mechanistic bases remain unclear. Nev-
ertheless, a physical interaction between FAN1 and
MLH1 has been documented, and this interaction has
been suggested to play a role in the DNA damage
response [108, 207–209]. Also, it has been suggested
that FAN1 binding to CAG extrusions may block
access of MutS such structures, thus preventing
CAG expansion [158, 210]. However, the functional
relevance of these interactions either in the context of
the error correction function of MMR or its mutagenic
role in CAG expansion remains to be elucidated.
Likewise, there is currently no data available on the
role of PMS1 in modulating CAG repeat expansion.
Future mechanistic studies evaluating the role of both
FAN1 and PMS1 will be required before a mechanis-
tic understanding accounting for all the implicated
activities can be constructed.
CONCLUSION
Implications for therapeutic interventions in HD
and/or other triplet repeat diseases
The convergence of evidence from human genet-
ics, mouse models, and biochemical studies has
highlighted the MMR pathway as a potential target
for therapeutic intervention in HD. Because MutS-
initiated processing of CAG and/or CTG extrusions
by MutL homologs is the presumptive proximal
step of the somatic expansion process, and since
human genetics have provided evidence supporting
the idea of somatic CAG expansion as a disease
onset driver, inactivation of MutS and/or one or
more of the MutL homologs is likely to impact
disease. Given the wealth of the available struc-
tural and biochemical information on the MMR
proteins, small molecule approaches for attenua-
tion of somatic CAG expansion may be particularly
tractable. Alternatively, recent advances in RNA-
based gene inactivation approaches also provide hope
that this avenue of therapeutically targeting MMR
genes may meet with success. Insofar as diseases
with such diverse pathophysiologies as HD, DM1,
FXD, and Friedreich’s ataxia share related underly-
ing mutational processes involving MMR, targeting
this pathway may result in treatments that benefit a
wide patient population.
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